A study found that continuous glucose monitoring (CGM) detected elevated glycemic metrics in women with gestational diabetes earlier in pregnancy compared to the standard oral glucose tolerance test (OGTT). The study involved 768 participants who wore a CGM device until delivery and were diagnosed with GDM using OGTT. Women with GDM had higher mean glucose levels, spent less time in optimal glycemic ranges, and experienced more hyperglycemia. The research suggests that CGM could be used to screen for hyperglycemia in pregnancy as early as the first trimester, potentially allowing for timely identification and treatment of dysglycemia. The study was led by Celeste Durnwald and published in Diabetes Care.
Source link